معرفی
Andrea Edginton is a Professor and Hallman Director at the University of Waterloo's Faculty of Science, serving as Associate Dean. Her research focuses on pharmacokinetics and physiologically based pharmacokinetic (PBPK) modeling, particularly in hemophilia treatment optimization, pediatric drug dosing, and obesity-related pharmacology. She leads initiatives like the WAPPS-Hemo platform for clotting factor concentrates and has contributed to studies on maternal medication exposure during breastfeeding. Edginton's work bridges clinical practice and computational modeling, addressing drug efficacy and safety in diverse populations, including critically ill children and patients with rare coagulation disorders.
Educational background: While not explicitly detailed in the text, her roles and research imply advanced training in pharmacy, pharmacology, or biomedical sciences. Research interests emphasize translational pharmacology, drug delivery mechanisms, and pediatric pharmacotherapy. She collaborates on global health projects, integrating real-world data with PBPK models to tailor treatments for hemophilia, neonatal care, and chronic illnesses.
Key contributions include developing predictive models for factor VIII prophylaxis, optimizing anakinra dosing in extracorporeal life support, and evaluating drug interactions in obese pediatric populations. Her work on maternal drug exposure via breast milk highlights translational research impacting child health policies. Edginton also contributes to open-source pharmacology tools like the Open Systems Pharmacology Suite.
Grant and advising activities are inferred from her research scope, though specific grants or student names are not listed. She is affiliated with the ConcePTION project for breastfeeding medication safety and the Kompetenznetz Hämostaseologie Ost (KHDO) in Germany. Her interdisciplinary approach spans academia, clinical practice, and industry collaborations, advancing personalized medicine strategies in hematology and pediatric pharmacology.
